A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

When diabetes warning signs go unnoticed, it may lead, to sever health complication. Here are a few symptoms one must know ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Fact checked by Jillian Dara The Food and Drug Administration (FDA) on Tuesday approved Ozempic (semaglutide) to reduce the ...

Managing type 2 diabetes involves complex treatment, workload, and costs that impose a significant burden on individuals, ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Recently, many people have learned about semaglutides and the good they're doing for diabetes and obesity. Medications like Ozempic, Wegovy, Mounjaro, and Rybelsus have received widespread attention, ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...